| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MARIZYME, INC. | 10%+ Owner | Common stock | 13,293,841 | $1,329,384 | $0.1000 | 21 Dec 2023 | BWL Investments Ltd |
| AQUABOUNTY TECHNOLOGIES INC | Director | Common Stock | 0 | $0 | $2.24 | 28 Oct 2025 | Direct |
| PMGC Holdings Inc. | Director, 10%+ Owner | Series B Preferred Stock | 3,336,437 | 26 Mar 2025 | By Northstrive Companies Inc. | ||
| MARIZYME, INC. | 10%+ Owner | 10% Secured Convertible Promissory Note | $0 | 21 Dec 2023 | BWL Investments Ltd |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AQB | AQUABOUNTY TECHNOLOGIES INC | 28 Oct 2025 | 0 | $0 | 3 | Director | 13 Nov 2025, 10:32 |
| ELAB | PMGC Holdings Inc. | 26 Mar 2025 | 1 | $0 | 4 | Director, 10%+ Owner | 28 Mar 2025, 21:47 |
| QLGN | Qualigen Therapeutics, Inc. | 08 Oct 2024 | 0 | $0 | 3 | Director | 17 Oct 2024, 16:05 |
| ELAB | Elevai Labs Inc. | 28 Dec 2023 | 0 | $0 | 3/A | 10%+ Owner | 16 Feb 2024, 21:50 |
| ELAB | Elevai Labs Inc. | 28 Dec 2023 | 0 | $0 | 3 | 10%+ Owner | 01 Feb 2024, 21:55 |
| MRZM | MARIZYME, INC. | 21 Dec 2023 | 2 | -$381,529 | 4 | 10%+ Owner | 28 Dec 2023, 20:06 |
| MRZM | MARIZYME, INC. | 26 Jun 2023 | 3 | -$36,594 | 4/A | 10%+ Owner | 08 Sep 2023, 10:22 |